Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
President Donald Trump said he would convene insurance companies in the coming weeks in a bid to pressure them to reduce costs for Americans who will see their premiums rise following the expiration of Obamacare subsidies at year’s end. “I’m going to call a meeting of the insurance companies,” Trump told reporters on Friday at ...
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now rein in Medicaid drug prices to match what they charged in other developed countries. As ...
In July, the Trump administration passed the One Big Beautiful Bill Act, otherwise known as the budget reconciliation bill. The law, H.R. 1, has made waves for its historic nearly $1 trillion cut to federal Medicaid spending over 10 years. Healthcare stakeholders have been vocal opponents of the move. H.R. 1 brings the first-ever national work requirements to the ...
House Minority Leader Hakeem Jeffries said Sunday he remains confident that Congress will extend expiring Affordable Care Act tax credits despite persistent opposition from Republicans. In a Sunday morning interview with ABC’s Jonathan Karl on “This Week,” Jeffries dismissed Senate Majority Leader John Thune’s remarks that a clean three-year extension of the credits would be ...
When UnitedHealth Group CEO Stephen Hemsley returned to the helm of the healthcare giant earlier this year, he committed to a deep review of the company’s processes in the wake of months of turmoil. UHG posted the results of the first independent audits conducted under this effort on Friday morning, with the initial reviews focusing on risk ...
The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to be cleared by regulators for obesity and possibly allowing many more Americans to access a highly effective treatment. The Wegovy pill, whose approval for weight loss was widely anticipated, ...
Thousands of middle-income Nevada residents are likely to lose subsidies easing the cost of health insurance purchased through public marketplaces despite steps from both parties to address the issue. Even with the lengthy back-and-forth over whether to extend the subsidies, Washington, D.C., observers say they’re expecting them to expire by the end of the year, just as ...
UPDATED: 7:45 p.m. on Dec. 17 The House of Representatives passed a Republican-led package that seeks to address the affordability of healthcare without an extension of the soon-to-expire Affordable Care Act subsidies. The 216-211 vote averted a last-ditch effort from Democrats and several moderate Republicans to force a vote on a subsidy extension. All Democrats ...
Employer-sponsored insurance may be getting costlier, but it still delivers a positive return for firms that cover their workers, according to a new Avalere Health analysis commissioned by the U.S. Chamber of Commerce and provided first to Axios. Why it matters: Workplace insurance is the backbone of the American health care system, covering around half of ...
For the millions of Americans who buy Affordable Care Act insurance, there’s still time left to enroll for 2026. But premium increases and the expiration of enhanced tax subsidies have led to larger-than-expected costs. Concerned shoppers, wondering if there’s anything they can do, are consulting insurance brokers or talking to representatives at ACA marketplace call ...